These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7796668)

  • 1. The role of superantigens in the immunobiology of retroviruses.
    Huber BT; Beutner U; Subramanyam M
    Ciba Found Symp; 1994; 187():132-40; discussion 140-3. PubMed ID: 7796668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens.
    Beutner U; Kraus E; Kitamura D; Rajewsky K; Huber BT
    J Exp Med; 1994 May; 179(5):1457-66. PubMed ID: 8163931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of superantigens in virus infection.
    Huber BT
    J Clin Immunol; 1995 Nov; 15(6 Suppl):22S-25S. PubMed ID: 8613488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of MMTV superantigen presentation in MHC class II-deficient mice.
    Beutner U; McLellan B; Kraus E; Huber BT
    Cell Immunol; 1996 Mar; 168(2):141-7. PubMed ID: 8640859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.
    Barnett A; Mustafa F; Wrona TJ; Lozano M; Dudley JP
    J Virol; 1999 Aug; 73(8):6634-45. PubMed ID: 10400761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
    Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
    J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse mammary tumor virus superantigens require N-linked glycosylation for effective presentation to T cells.
    McMahon CW; Bogatzki LY; Pullen AM
    Virology; 1997 Feb; 228(2):161-70. PubMed ID: 9123822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
    Wrona TJ; Lozano M; Binhazim AA; Dudley JP
    J Virol; 1998 Jun; 72(6):4746-55. PubMed ID: 9573239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus.
    Held W; Waanders GA; MacDonald HR; Acha-Orbea H
    Int Immunol; 1994 Sep; 6(9):1403-7. PubMed ID: 7819149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus.
    Held W; Shakhov AN; Izui S; Waanders GA; Scarpellino L; MacDonald HR; Acha-Orbea H
    J Exp Med; 1993 Feb; 177(2):359-66. PubMed ID: 8093892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of a MHC class II transgene determines both superantigenicity and susceptibility to mammary tumor virus infection.
    Pucillo C; Cepeda R; Hodes RJ
    J Exp Med; 1993 Oct; 178(4):1441-5. PubMed ID: 8397273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection.
    Golovkina TV; Dudley JP; Jaffe AB; Ross SR
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4828-32. PubMed ID: 7761408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
    Ando Y; Wajjwalku W; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
    J Immunol; 1995 Jun; 154(12):6219-26. PubMed ID: 7759859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
    Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
    Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features.
    Labrecque N; McGrath H; Subramanyam M; Huber BT; Sékaly RP
    J Exp Med; 1993 Jun; 177(6):1735-43. PubMed ID: 8388432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
    Golovkina TV; Dudley JP; Ross SR
    J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
    Hodes RJ; Novick MB; Palmer LD; Knepper JE
    J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression.
    Xu L; Wrona TJ; Dudley JP
    Virology; 1996 Jan; 215(2):113-23. PubMed ID: 8560758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transposon-mediated random insertions and site-directed mutagenesis prevent the trafficking of a mouse mammary tumor virus superantigen.
    McMahon CW; Traxler B; Grigg ME; Pullen AM
    Virology; 1998 Apr; 243(2):354-65. PubMed ID: 9568034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class II limits the functional expression of endogenous superantigens in B cells.
    Lund FE; Randall TD; Woodland DL; Corley RB
    J Immunol; 1993 Jan; 150(1):78-86. PubMed ID: 8380190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.